相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Reduced H3K27me3 levels in diffuse gliomas: association with 1p/19q codeletion and difference from H3K27me3 loss in malignant peripheral nerve sheath tumors
Keiichiro Kitahama et al.
BRAIN TUMOR PATHOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
Daniel J. Brat et al.
ACTA NEUROPATHOLOGICA (2020)
Mini-symposium in medulloblastoma genomics in the modern molecular era
David W. Ellison
BRAIN PATHOLOGY (2020)
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading
David N. Louis et al.
BRAIN PATHOLOGY (2020)
Alpha Internexin: A Surrogate Marker for 1p/19q Codeletion and Prognostic Marker in Anaplastic (WHO grade III) Gliomas
K. S. Rajmohan et al.
NEUROLOGY INDIA (2020)
Practical procedures for the integrated diagnosis of astrocytic and oligodendroglial tumors
Yukihiko Sonoda et al.
BRAIN TUMOR PATHOLOGY (2019)
Overview of DNA methylation in adult diffuse gliomas
Kosuke Aoki et al.
BRAIN TUMOR PATHOLOGY (2019)
cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation
David W. Ellison et al.
ACTA NEUROPATHOLOGICA (2019)
A simple algorithmic approach using histology and immunohistochemistry for the current classification of adult diffuse glioma in a resource-limited set-up
R. T. Rajeswarie et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2018)
cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2018)
Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion
Akane Yamamichi et al.
BRAIN TUMOR PATHOLOGY (2018)
cIMPACT-NOW update 3: recommended diagnostic criteria for Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV
Daniel J. Brat et al.
ACTA NEUROPATHOLOGICA (2018)
Immunohistochemistry on old archival paraffin blocks: is there an expiry date?
Federica Grillo et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT
Melike Pekmezci et al.
ACTA NEUROPATHOLOGICA (2017)
Combined ATRX/IDH1 immunohistochemistry predicts genotype of oligoastrocytomas
Ekkehard Hewer et al.
HISTOPATHOLOGY (2016)
Loss of antigenicity with tissue age in breast cancer
Susan E. Combs et al.
LABORATORY INVESTIGATION (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas
Shingo Takano et al.
BRAIN TUMOR PATHOLOGY (2016)
A high-sensitive HMab-2 specifically detects IDH1-R132H, the most common IDH mutation in gliomas
Yuki Fujii et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Mutational landscape and clonal architecture in grade II and III gliomas
Hiromichi Suzuki et al.
NATURE GENETICS (2015)
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
Heather E. Leeper et al.
ONCOTARGET (2015)
Revisiting TP53 Mutations and Immunohistochemistry-A Comparative Study in 157 Diffuse Gliomas
Hirokazu Takami et al.
BRAIN PATHOLOGY (2015)
Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas
Yukinari Kato
BRAIN TUMOR PATHOLOGY (2015)
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
Gregory Cairncross et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
IDH Mutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower Grade Diffuse Astrocytic Glioma
Daniel Gorovets et al.
CLINICAL CANCER RESEARCH (2012)
Anaplastic oligodendroglial tumors: Refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402
Caterina Giannini et al.
BRAIN PATHOLOGY (2008)